- £46.93bn
- £55.63bn
- $35.57bn
- 77
- 26
- 68
- 60
Annual balance sheet for CRH, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | 10-K |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,721 | 5,783 | 5,936 | 6,341 | 3,881 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,636 | 4,093 | 4,300 | 4,507 | 4,820 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,977 | 14,044 | 14,833 | 16,885 | 14,083 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 19,317 | 19,502 | 18,943 | 19,133 | 22,726 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 44,944 | 44,670 | 45,319 | 47,469 | 50,613 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,465 | 7,581 | 8,041 | 10,013 | 10,296 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 25,288 | 24,437 | 23,162 | 26,615 | 29,006 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 19,656 | 20,233 | 22,157 | 20,854 | 21,607 |
Total Liabilities & Shareholders' Equity | 44,944 | 44,670 | 45,319 | 47,469 | 50,613 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |